PathogenDx Pivot From COVID-19 Pandemic Shows Benefits of Microarray Technology
March 28, 2024
The COVID-19 pandemic quickly placed PathogenDx diagnostic testing at the forefront of the response to the worldwide health emergency, and kicked off the development of the D3 ArrayTM technology. PathogenDx has taken our platform, which we used to successfully create COVID tests during the pandemic, to identify urinary tract infections (UTIs).
Back »
